Cuperus, Liz J. A.
van der Palen, Job
Aldenkamp, Arnoud
van Huisstede, Astrid
Bischoff, Erik W. M. A.
van Boven, Job F. M.
Brijker, Folkert
Dik, Stephan
van Excel, Jeroen A. J. M.
Goosens, Martijn
van Hal, Peter Th. W.
Kuijvenhoven, Jolanda C.
Kunz, Lisette I. Z.
Vasbinder, Erwin C.
Kerstjens, Huib A. M.
in ’t Veen, Johannes C. C. M.
van der Poel, Marjo
Amelink, Marijke
Rol, Anke
de Graaf, Jennifer
Hirmann, Petra
van Tour, Fleur
Jordens, Elly
Alfing, Lydia
Lenderink, Gerda
Rupert, Thecla
Rietveld, Truus
van Campen, Jasmijn
de Bruijn, Jantine
ter Burg, Janice
van Litsenburg, Walter
Knoops, Len
Eggermont-Schilt, Margot
de Waard-Heijligers, Manon
Paalvast-Schouten, Ilonka
van Oord, Sarah
,
Funding for this research was provided by:
Chiesi Pharmaceuticals B.V (Unrestricted grant for faculty)
Article History
Received: 16 February 2024
Accepted: 2 May 2024
First Online: 4 July 2024
Declarations
:
: Ethics approval for the Tricolon study was waived by the Medical research Ethics Committees United (NL79938.100.22). This study is performed after approval by the Institutional Research Board and Board of Directors of the participating hospitals. The study is registered at clinicaltrials.gov (NCT05495698). Informed consent was obtained from all subjects.
: Not Applicable.
: LC: none.JvdP: none.AA: none.AvH: none.EB: unrestricted grants and speaking fees received from Chiesi Pharmaceuticals B.V., Boehringer Ingelheim bv, GlaxoSmithKline.JvB: received unrestricted research grants from Aardex, AstraZeneca, Chiesi, European Commission COST Action 19132 (ENABLE), European Respiratory Society CRC “CONNECT”, Novartis, Pfizer, Pill Connect, Trudell Medical and consultancy/speaker fees from AstraZeneca, Chiesi, GSK, Novartis, Teva and Vertex. All payments were unrelated to this manuscript and all paid to his institution (UMCG).FB: none.SD: none.JvE: none.MG: none.PvH: none.JK: none.LK: received speaker fees from AZ.EV: received unrestricted research grants from AstraZeneca and Pfizer.HK: reports grants and consultancy/advisory board participation from/for AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, and Novartis, all outside the submitted work. All were paid to his institution.JiV: received unrestricted faculty research grants from GSK, Teva, AZ, Chiesi, Sanofi, and speaker fees from AZ, GSK, Sanofi, Chiesi, Stichting RoLeX and Health Investment.